FDA Reorganization Will Not Include John Taylor As Top Aide To Commissioner

John Taylor’s exit from the agency comes as FDA Commissioner Margaret Hamburg awaits recommendations from a panel of senior agency officials on how to ensure the centers support Office of Regulatory Affairs’ activities without duplication.

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Regulation

More from Policy & Regulation